Prestige Consumer Healthcare Inc. (NYSE:PBH) Q1 2023 Earnings Conference Call August 4, 2022 8:30 AM ET
Company Participants
Phil Terpolilli - Vice President, Investor Relations and Treasurer
Ron Lombardi - Chairman, President and CEO
Christine Sacco - Chief Financial Officer
Conference Call Participants
Chris Neamonitis - Jefferies
Jon Andersen - William Blair
Mitch Pinheiro - Sturdivant
Erica Eiler - Oppenheimer
Linda Bolton Weiser - D.A. Davidson
Operator
Good morning. And welcome to the Prestige Consumer Healthcare Fiscal 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]
Please note, this event is being recorded. I would now like to turn the conference over to Phil Terpolilli, Vice President of Investor Relations and Treasurer. Please go ahead.
Phil Terpolilli
Thanks, Operator. Thank you to everyone who’s joined today. On the call with me are Ron Lombardi, our Chairman, President and CEO; and Christine Sacco, our CFO. On today’s call, we will review our first quarter fiscal 2023 results, discuss our full year outlook and take questions from analysts.
A slide presentation accompanies today’s call, we can access it by visiting prestigeconsumerhealthcare.com, clicking on the Investors link and then on today’s Webcast and Presentation.
Remember some of the information contained in the presentation today include non-GAAP financial measures. Reconciliations to the nearest GAAP financial measures are included in the earnings release and slide presentation.
On today’s call management will make forward-looking statements around risks and uncertainties, which are detailed in a complete Safe Harbor disclosure on page two of the slide presentation that accompanies the call.
These are important to review and contemplate, business environment uncertainty remains heightened due to COVID 19 and various other geopolitical factors, which have numerous potential impacts.
This means results could change at any time and the forecasted impact of risk consideration to the best estimate based on the information available as of today’s date. Further information concerning risk factors and cautionary statements are available on our most recent SEC filings and most recent company 10-K.
I now hand it over to our CEO, Ron Lombardi. Ron?
Ron Lombardi
Thanks, Phil. Let’s begin on slide five. We are pleased with our start to the year, which continues the momentum from our record fiscal 2022, which we completed back in March. This success is driven by the business attributes of our leading 100% consumer healthcare platform and the execution of our time tested value creation strategy.